A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)

PHASE4CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

February 11, 2022

Primary Completion Date

February 13, 2024

Study Completion Date

February 13, 2024

Conditions

Osteoporosis

Interventions

DRUG

Zoledronic acid, once

Intravenous infusion of 5mg zoledronic acid, once

DRUG

Zoledronic acid, twice

Intravenous infusion of 5mg zoledronic acid for 6month interval, twice

Trial Locations (1)

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER